Insulin / Sulfonylharnstoff: 2. Symposium "Kombinationstherapie Insulin / Sulfonylharnstoff bei Typ II-Diabetes", Oktober 1986
Saved in:
| Main Author: | |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Basel
S. Karger
1988
|
| Subjects: | |
| Online Access: | DE-703 Volltext |
| Physical Description: | 1 Online-Ressource (VIII + 168 Seiten) |
| ISBN: | 9783318047875 |
Staff View
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046315876 | ||
| 003 | DE-604 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 191220s1988 xx o|||| 00||| eng d | ||
| 020 | |a 9783318047875 |9 978-3-318-04787-5 | ||
| 035 | |a (ZDB-25-KAG)221330 | ||
| 035 | |a (OCoLC)1073857046 | ||
| 035 | |a (DE-599)BVBBV046315876 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-703 | ||
| 084 | |a XI 4900 |0 (DE-625)153009:12905 |2 rvk | ||
| 100 | 1 | |a Bachmann, W. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Insulin / Sulfonylharnstoff |b 2. Symposium "Kombinationstherapie Insulin / Sulfonylharnstoff bei Typ II-Diabetes", Oktober 1986 |
| 264 | 1 | |a Basel |b S. Karger |c 1988 | |
| 300 | |a 1 Online-Ressource (VIII + 168 Seiten) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 650 | 4 | |a Metabolism | |
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Endocrinology | |
| 650 | 4 | |a Internal Medicine | |
| 650 | 4 | |a Metabolic Diseases | |
| 650 | 0 | 7 | |a Insulin |0 (DE-588)4027221-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Diabetes mellitus Typ 2 |0 (DE-588)1194598587 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kombinationstherapie |0 (DE-588)4194534-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Sulfonylharnstoffderivate |0 (DE-588)4194531-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1986 |z München |2 gnd-content | |
| 689 | 0 | 0 | |a Diabetes mellitus Typ 2 |0 (DE-588)1194598587 |D s |
| 689 | 0 | 1 | |a Sulfonylharnstoffderivate |0 (DE-588)4194531-1 |D s |
| 689 | 0 | 2 | |a Insulin |0 (DE-588)4027221-7 |D s |
| 689 | 0 | 3 | |a Kombinationstherapie |0 (DE-588)4194534-7 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Sulfonylharnstoffderivate |0 (DE-588)4194531-1 |D s |
| 689 | 1 | 1 | |a Insulin |0 (DE-588)4027221-7 |D s |
| 689 | 1 | 2 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 1 | |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-3-8055-4601-0 |
| 856 | 4 | 0 | |u https://karger.com/books/book/1834 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-25-KAG | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-031692963 | |
| 966 | e | |u https://karger.com/books/book/1834 |l DE-703 |p ZDB-25-KAG |x Verlag |3 Volltext | |
Record in the Search Index
| _version_ | 1828314760341356544 |
|---|---|
| adam_text | |
| any_adam_object | |
| author | Bachmann, W. |
| author_facet | Bachmann, W. |
| author_role | aut |
| author_sort | Bachmann, W. |
| author_variant | w b wb |
| building | Verbundindex |
| bvnumber | BV046315876 |
| classification_rvk | XI 4900 |
| collection | ZDB-25-KAG |
| ctrlnum | (ZDB-25-KAG)221330 (OCoLC)1073857046 (DE-599)BVBBV046315876 |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zc 4500</leader><controlfield tag="001">BV046315876</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">191220s1988 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783318047875</subfield><subfield code="9">978-3-318-04787-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-25-KAG)221330</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1073857046</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046315876</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 4900</subfield><subfield code="0">(DE-625)153009:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bachmann, W.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Insulin / Sulfonylharnstoff</subfield><subfield code="b">2. Symposium "Kombinationstherapie Insulin / Sulfonylharnstoff bei Typ II-Diabetes", Oktober 1986</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel</subfield><subfield code="b">S. Karger</subfield><subfield code="c">1988</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (VIII + 168 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrinology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolic Diseases</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Insulin</subfield><subfield code="0">(DE-588)4027221-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Diabetes mellitus Typ 2</subfield><subfield code="0">(DE-588)1194598587</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kombinationstherapie</subfield><subfield code="0">(DE-588)4194534-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sulfonylharnstoffderivate</subfield><subfield code="0">(DE-588)4194531-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1986</subfield><subfield code="z">München</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Diabetes mellitus Typ 2</subfield><subfield code="0">(DE-588)1194598587</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Sulfonylharnstoffderivate</subfield><subfield code="0">(DE-588)4194531-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Insulin</subfield><subfield code="0">(DE-588)4027221-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Kombinationstherapie</subfield><subfield code="0">(DE-588)4194534-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Sulfonylharnstoffderivate</subfield><subfield code="0">(DE-588)4194531-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Insulin</subfield><subfield code="0">(DE-588)4027221-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-3-8055-4601-0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://karger.com/books/book/1834</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-25-KAG</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031692963</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://karger.com/books/book/1834</subfield><subfield code="l">DE-703</subfield><subfield code="p">ZDB-25-KAG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1986 München gnd-content |
| genre_facet | Konferenzschrift 1986 München |
| id | DE-604.BV046315876 |
| illustrated | Not Illustrated |
| indexdate | 2025-04-02T18:00:28Z |
| institution | BVB |
| isbn | 9783318047875 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031692963 |
| oclc_num | 1073857046 |
| open_access_boolean | |
| owner | DE-703 |
| owner_facet | DE-703 |
| physical | 1 Online-Ressource (VIII + 168 Seiten) |
| psigel | ZDB-25-KAG |
| publishDate | 1988 |
| publishDateSearch | 1988 |
| publishDateSort | 1988 |
| publisher | S. Karger |
| record_format | marc |
| spelling | Bachmann, W. Verfasser aut Insulin / Sulfonylharnstoff 2. Symposium "Kombinationstherapie Insulin / Sulfonylharnstoff bei Typ II-Diabetes", Oktober 1986 Basel S. Karger 1988 1 Online-Ressource (VIII + 168 Seiten) txt rdacontent c rdamedia cr rdacarrier Metabolism Diabetes Endocrinology Internal Medicine Metabolic Diseases Insulin (DE-588)4027221-7 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Diabetes mellitus Typ 2 (DE-588)1194598587 gnd rswk-swf Kombinationstherapie (DE-588)4194534-7 gnd rswk-swf Sulfonylharnstoffderivate (DE-588)4194531-1 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1986 München gnd-content Diabetes mellitus Typ 2 (DE-588)1194598587 s Sulfonylharnstoffderivate (DE-588)4194531-1 s Insulin (DE-588)4027221-7 s Kombinationstherapie (DE-588)4194534-7 s DE-604 Pharmakotherapie (DE-588)4076066-2 s Erscheint auch als Druck-Ausgabe 978-3-8055-4601-0 https://karger.com/books/book/1834 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Bachmann, W. Insulin / Sulfonylharnstoff 2. Symposium "Kombinationstherapie Insulin / Sulfonylharnstoff bei Typ II-Diabetes", Oktober 1986 Metabolism Diabetes Endocrinology Internal Medicine Metabolic Diseases Insulin (DE-588)4027221-7 gnd Pharmakotherapie (DE-588)4076066-2 gnd Diabetes mellitus Typ 2 (DE-588)1194598587 gnd Kombinationstherapie (DE-588)4194534-7 gnd Sulfonylharnstoffderivate (DE-588)4194531-1 gnd |
| subject_GND | (DE-588)4027221-7 (DE-588)4076066-2 (DE-588)1194598587 (DE-588)4194534-7 (DE-588)4194531-1 (DE-588)1071861417 |
| title | Insulin / Sulfonylharnstoff 2. Symposium "Kombinationstherapie Insulin / Sulfonylharnstoff bei Typ II-Diabetes", Oktober 1986 |
| title_auth | Insulin / Sulfonylharnstoff 2. Symposium "Kombinationstherapie Insulin / Sulfonylharnstoff bei Typ II-Diabetes", Oktober 1986 |
| title_exact_search | Insulin / Sulfonylharnstoff 2. Symposium "Kombinationstherapie Insulin / Sulfonylharnstoff bei Typ II-Diabetes", Oktober 1986 |
| title_full | Insulin / Sulfonylharnstoff 2. Symposium "Kombinationstherapie Insulin / Sulfonylharnstoff bei Typ II-Diabetes", Oktober 1986 |
| title_fullStr | Insulin / Sulfonylharnstoff 2. Symposium "Kombinationstherapie Insulin / Sulfonylharnstoff bei Typ II-Diabetes", Oktober 1986 |
| title_full_unstemmed | Insulin / Sulfonylharnstoff 2. Symposium "Kombinationstherapie Insulin / Sulfonylharnstoff bei Typ II-Diabetes", Oktober 1986 |
| title_short | Insulin / Sulfonylharnstoff |
| title_sort | insulin sulfonylharnstoff 2 symposium kombinationstherapie insulin sulfonylharnstoff bei typ ii diabetes oktober 1986 |
| title_sub | 2. Symposium "Kombinationstherapie Insulin / Sulfonylharnstoff bei Typ II-Diabetes", Oktober 1986 |
| topic | Metabolism Diabetes Endocrinology Internal Medicine Metabolic Diseases Insulin (DE-588)4027221-7 gnd Pharmakotherapie (DE-588)4076066-2 gnd Diabetes mellitus Typ 2 (DE-588)1194598587 gnd Kombinationstherapie (DE-588)4194534-7 gnd Sulfonylharnstoffderivate (DE-588)4194531-1 gnd |
| topic_facet | Metabolism Diabetes Endocrinology Internal Medicine Metabolic Diseases Insulin Pharmakotherapie Diabetes mellitus Typ 2 Kombinationstherapie Sulfonylharnstoffderivate Konferenzschrift 1986 München |
| url | https://karger.com/books/book/1834 |
| work_keys_str_mv | AT bachmannw insulinsulfonylharnstoff2symposiumkombinationstherapieinsulinsulfonylharnstoffbeitypiidiabetesoktober1986 |